The committee voted that FDA should restrict use of LYNPARZA plus abi/pred to these BRCAm mCRPC patients
Clinic will offer Comprehensive Genetic Counselling and Testing Services to empower patients with personalized care
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
The news on a shift in its focus comes after the refinement of Bayer’s early innovation framework
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution
Gafchromic films support patient care in oncology
Franson will help biopharma clients design a phased approach to inform and execute clinical development plans
Subscribe To Our Newsletter & Stay Updated
